Communicating Risk

Clinical prediction models (CPMs) predict the future outcomes of individual patients have grown in number and importance in cancer care. The malignancy that has attracted perhaps the greatest recent interest and activity in predictive modeling is prostate cancer. For populations of patients, the comparative effectivness of these interventions is either equivalent or unknown. CPMs have thus been increasingly advocated for by researchers and clinicians. Despite this increase, we know little about whether they are achieving their intended goal of promoting rational and informed decision making. 

We need to know how CPMs can be improved to best meet the needs of patients. We therefore propose a formative, qualitative study to begin to answer these questions. Specific aims include:

  1. To describe the extent of prostate cancer survivors' experiences with CPMs, the settings and circimstances in which they have been exposed to CPMs and individualized risk information, and their perceptions of the value of this information in decision making
  2. To assess prostate cancer surviviors' understanding of individualized risk information about prostate cancer treatment outcomes, and to identify potential barriers to understanding.
  3. To elicit prostate cancer survivors' views on how existing CPMs might be made more patient-centered, and their reactions to novel alternative risk communication methods. 
Organization: 
Maine Medical Center
Grant Amount Given: 
$9,413
Year Issued: 
2011
Period: 
Fall
Grant Category: 
Education
Types of Cancer: 
Prostate
Grant Duration: 
1 Year Pilot Grant

Maine Cancer Foundation Grants to this Organization:

Year Program Amount Category Organization
2016 Building Capacity at MaineHealth to Enahance Colorectal Cancer Screening $28,863 Screening Maine Medical Center
2016 The Maine Lung Cancer Prevention and Screening (Maine LungCAPS) Initiative $400,000 Prevention Maine Medical Center
2015 Extending Lung Cancer Screening to Primary Care $49,899 Screening Maine Medical Center
2013 Lung Cancer Screening Shared Decision-Making $25,536 Screening Maine Medical Center
2013 Endometrial Cancer & Obesity: A Survivorship Program $10,000 Survivorship Maine Medical Center
2012 Gas Cards for Emergency Aid $1,000 Beacon Fund Maine Medical Center
2012 Inhibitory Effects of Insulin-like Growth Factor Binding Protein-4(IGFBP-4) on Melanoma Growth and Metastasis $73,848 Research Maine Medical Center
2012 Improving Colorectal Cencer Screenings in Low-Income Primary Care Settings Using Shared Decision Making $97,860 Research Maine Medical Center
2012 Cancer Survivorship Support $10,000 Survivorship Maine Medical Center
2012 Oncology Pharmacy Practice Residency $5,000 Support Maine Medical Center
2011 Small Molecule Inhibitors of Twist1 Function to Inhibit Tumor Progression $73,039 Research Maine Medical Center
2011 FGF Export from Endothelial Cells: Protumorigenic Potential and Methods of Regulation $86,877 Research Maine Medical Center
2011 Validating Prediction Tools for Prostate Cancer Quality of Life Outcomes $71,029 Research Maine Medical Center
2011 Increase Immigrant Screening $8,011 Screening Maine Medical Center
2011 Communicating Risk $9,413 Education Maine Medical Center
2011 Notch Regulation of the Tumor Supressor miR-145 in Breast Cancer Cells $94,184 Research Maine Medical Center
2011 Inceptive Role of miR-199b in Acute Myeloid Leukemia $92,000 Research Maine Medical Center
2009 Predicting Quality of Life Outcomes after Prostate Cancer Treatment $45,295 Research Maine Medical Center
2006 Reduction of breast cancer by the Notch signaling pathway $35,000 Research Maine Medical Center
2001 Ronald J . Carroll, M.D. Lecture Fund at Maine Medical Center $10,000 Education Maine Medical Center
1979 Pediatric Cancer Seminar Education Maine Medical Center